Product ID |
Product Name |
CAS# |
Purity |
Y3306653 |
ZM223 |
2031177-48-5 |
99% |
Y3104177 |
3-Fluoro-L-phenylalanine methyl ester HCl |
176896-74-5 |
97% |
Y3298182 |
GSK620 |
2088410-46-0 |
98% |
Y3104176 |
Yunaconitoline |
259099-25-7 |
96.5% |
Y3251310 |
Compound 3A |
1822358-25-7 |
98% |
Y3313756 |
Carmichaenine C |
2065228-61-5 |
97.0% |
Y3308577 |
Aviptadil Acetate |
1444827-29-5 |
100% |
Y3104266 |
Afzelechin 3-O-xyloside |
512781-45-2 |
98.0% |
Y3104368 |
5''-O-Acetyljuglanin |
885697-82-5 |
powder |
Y3306327 |
CMP8 |
851107-28-3 |
99% |
Y3315157 |
Pulchinenoside E2 |
244202-36-6 |
98% |
Y1263306 |
I-191 |
1690172-25-8 |
98% |
Y3289081 |
Carbetocin acetate(37025-55-1 free base) |
1631754-28-3 |
99% |
Y3290377 |
(Z)-4EGI-1 |
901787-88-0 |
98% |
Y3252066 |
HSK0935 |
1638851-44-1 |
96% |
Y1263307 |
SBI-553 |
1849603-72-0 |
99% |
Y3314932 |
5-Epicanadensene |
220384-17-8 |
95% |
Y3248164 |
Firuglipel |
1371591-51-3 |
99% |
Y3318697 |
Tasumatrol L |
847835-17-0 |
98.0% |
Y1263314 |
SM-276001 |
473930-22-2 |
99% |
Y3106413 |
Yadanzioside F |
95258-11-0 |
98.0% |
Y3317801 |
2-Hydroxy-3-methoxybenzoic acid glucose ester |
172377-87-6 |
98.0% |
Y1263367 |
Di-O-methyldemethoxycurcumin |
824951-60-2 |
97% |
Y1344501 |
X5050 |
2404756-81-4 |
98% |
Y1342651 |
ZZW-115 hydrochloride |
10122-45-9 |
98% |
Y3311892 |
Burixafor hydrobromide |
1191450-19-7 |
98.0% |
Y1340046 |
Thalidomide-NH-C6-NH2 TFA |
2093386-51-5 |
98% |
Y3104369 |
10-Deacetylyunnanxane |
1333323-17-3 |
96.5% |
Y3104353 |
N-Boc-2-(2-azidoethoxy)ethanamine |
176220-30-7 |
97% |
Y3312678 |
9-Hydroxy-nonanoic acid tert-butyl ester |
171926-99-1 |
97% |
Y3315126 |
Bacopaside IV |
155545-03-2 |
98% |
Y3297618 |
Aganepag |
910562-18-4 |
99% |
Y3314267 |
2-Deacetyltaxachitriene A |
214769-96-7 |
95% |
Y3305012 |
Taxachitriene B |
167906-75-4 |
98.0% |
Y3308770 |
CRTh2 antagonist 1 |
1379445-54-1 |
97% |
Y3296281 |
BBIQ |
1229024-57-0 |
99% |
Y3104469 |
1-Azido-9-bromo-nonane |
1262683-54-4 |
97% |
Y3315086 |
9-Hydroxyeriobofuran |
167278-41-3 |
95% |
Y3318673 |
2-Deacetyltaxuspine X |
259678-73-4 |
95% |
Y3318374 |
Hispanone |
82462-67-7 |
99.0% |
Y3267642 |
IL-17A antagonist 1 |
2205034-18-8 |
99% |
Y1232699 |
GW274150 phosphate |
438542-15-5 |
98% |
Y3317937 |
Dodovislactone B |
1616683-55-6 |
95% |
Y3259496 |
TLR7 agonist 1 |
2178156-33-5 |
98% |
Y1259071 |
Zabofloxacin hydrochloride |
623574-00-5 |
98% |
Y3316131 |
KRAS G12C inhibitor 16 |
2349392-79-4 |
100% |
Y3295229 |
OTS514 hydrochloride(1338540-63-8(free base)) |
2319647-76-0 |
97% |
Y3296638 |
Curcumaromin B |
1810034-39-9 |
95% |
Y3104585 |
Ned 19 |
874374-25-1 |
98% |
Y1232850 |
MMP13-IN-3 |
1222173-37-6 |
99% |
Y3316364 |
Nardosinonediol |
20489-11-6 |
97.0% |
Y1333607 |
(4S)-1-Boc-4-benzyloxy-D-proline |
1610436-78-6 |
97% |
Y3305408 |
(+)-KCC2 blocker 1 |
1228439-71-1 |
98% |
Y3316171 |
Taxezopidine L |
219749-76-5 |
98.0% |
Y3309806 |
DHODH-IN-1 |
1800296-63-2 |
99% |
Y3314555 |
Isodaphnoretin B |
944824-29-7 |
95% |
Y3304643 |
AMG-1694 |
1361217-07-3 |
97% |
Y3104269 |
Kanshone H |
1445952-33-9 |
98.0% |
Y3310204 |
DHODH-IN-15 |
1364791-88-7 |
97% |
Y3307523 |
CGRP antagonist 1 |
1123757-49-2 |
100% |
Y3308184 |
Quercetin 3-O-sophoroside-7-O-rhamnoside |
64828-40-6 |
95% |
Y1333648 |
N-Fmoc-O-phenyl-L-serine |
1401662-77-8 |
97% |
Y3312643 |
Plantanone B |
55780-30-8 |
98% |
Y1334578 |
(4S)-1-Fmoc-4-benzyloxy-D-proline |
839719-78-7 |
97% |
Y1237078 |
IK1 inhibitor PA-6 |
500715-03-7 |
98% |
Y3257350 |
KDM4-IN-2 |
2369607-62-3 |
98% |
Y3311107 |
MK-0941 free base |
752240-01-0 |
98% |
Y1237080 |
Cbz-N-Me-Arg(Pbf)-OH |
2135655-88-6 |
97% |
Y3312422 |
5-Hydroxy-6,7,8-trimethoxycoumarin |
1581248-32-9 |
97.0% |
Y3243991 |
Etamicastat hydrochloride |
677773-32-9 |
98% |
Y1237188 |
CM-675 |
1872466-47-1 |
99% |
Y3254138 |
(4S)-4-Methoxy-L-proline methyl ester HCl |
2411180-81-7 |
95% |
Y3104549 |
(4R)-4-Methoxy-L-proline methyl ester HCl |
76391-36-1 |
97% |
Y3297543 |
Homoeriodictyol 7-O-glucoside |
14982-11-7 |
98.0% |
Y3313521 |
(R)-2-(Boc-amino)-4-iodobutanoic acid benzyl ester |
1286768-64-6 |
97% |
Y3260079 |
SMAP-2 |
1809068-70-9 |
99% |
Y1237120 |
HSP27 inhibitor J2 |
2133499-85-9 |
99% |
Y3312843 |
Chlorovaltrate K |
96801-92-2 |
95% |
Y3306826 |
DHODH-IN-9 |
1644156-41-1 |
99% |
Y3318246 |
N-Fmoc-N-[4-(tert-butoxy)-4-oxobutyl]glycine |
174799-90-7 |
97% |
Y1241595 |
MA-0204 |
2095128-17-7 |
99% |
Y1237136 |
PfDHODH-IN-2 |
425629-94-3 |
99% |
Y3318576 |
14-(Boc-amino)-tetradecan-1-ol |
1227180-96-2 |
97% |
Y3292722 |
Deltasonamide 2 (TFA) |
2235358-74-2 |
99% |
Y3296156 |
Stachybotramide |
149598-71-0 |
97.5% |
Y1337996 |
N3-PEG6-CH2COOH |
880129-82-8 |
97% |
Y3290336 |
1-(Boc-amino)-3-bromobutane |
1504338-47-9 |
90% |
Y3314693 |
Vitedoin A |
819861-40-0 |
95% |
Y1237202 |
Autotaxin-IN-3 |
2156655-68-2 |
98% |
Y3318417 |
Latisxanthone C |
197447-32-8 |
95% |
Y3310249 |
N-Fmoc-(4-azidobutyl)glycine |
2250433-81-7 |
99% (HPLC, TLC) |
Y1241666 |
TMP780 |
1422053-03-9 |
99% |
Y1237108 |
N2-Fmoc-N5,N5-dimethyl-L-glutamine |
1146118-59-3 |
95% |
Y3316857 |
7beta-Methoxyrosmanol |
24703-38-6 |
98% |
Y3317081 |
7-Prenyljacareubin |
94513-60-7 |
95% |
Y1237173 |
GNE-618 |
1362151-42-5 |
99% |
Y3104445 |
N3-PEG2-Tos |
182347-24-6 |
98% |
Y1237109 |
LolCDE-IN-1 |
1639933-78-0 |
99% |
Y3317011 |
1,5,6-Trihydroxy-3,7-dimethoxyxanthone |
65008-02-8 |
95% |
Y3104458 |
Shizukaol A |
131984-98-0 |
95.0% |